Notable OPCRD Publications

Notable OPCRD Publications

List of notable journal articles using data from the OPC Research Database.


Price D, Kaplan A, Jones R, Freeman D, Burden A, Gould S, von Ziegenweidt J, Ali M, King C,

Thomas M. (2015) Long-acting muscarinic antagonist use in adults with asthma: real-life

prescribing and outcomes of add-on therapy with tiotropium bromide. J Asthma Allergy;8:1-

13. doi: 10.2147/JAA.S76639.


Postma DS, Roche N, Colice G, Israel E, Martin RJ, Van Aalderen WM, Grigg J, Burden A,

Hillyer EV, Von Ziegenweidt J, Gopala G, Price D (2014) Comparing the effectiveness of

small-particle versus large-particle inhaled corticosteroid in COPD. Int J Chrin Obstruct

Pulmon Dis. 2014 Oct 17;9:1163-86. doi: 10.2147/COPD.S68289.


Martin RJ, Price D, Roche N, Israel E, van Aalderen WM, Grigg J, Postma DS, Guilbert TW,

Hillyer EV, Burden A, von Ziegenweidt J, Colice G. (2014) Cost-effectiveness of initiating

extrafine- or standard size-particle inhaled corticosteroid for asthma in two health-care

systems: a retrospective matched cohort study. NPJ Prim Care Respir Med. 2014 Oct

9;24:14081. doi: 10.1038/npjpcrm.2014.81.


Price D, West D, Brusselle G, Gruffydd-Jones K, Jones R, Miravitlles M, Rossi A, Hutton C,

Ashton VL, Stewart R, Bichel K. (2014) Management of COPD in the UK primary-care setting:

an analysis of real-life prescribing patterns Int J Chron Obstruct Pulmon Dis. 2014 Aug

27;9:889-904. doi: 10.2147/COPD.S62750.


Price D, Thomas V, von Ziegenweidt J, Gould S, Hutton C, King C (2014). Switching patients

from other inhaled corticosteroid devices to the Easyhaler(®): historical, matched-cohort

study of real-life asthma patients. J Asthma Allergy. 2014 Apr 10;7:31-51. doi:



Jones RC, Price D, Ryan D, Sims EJ, von Ziegenweidt J, Mascarenhas L, Burden A, Halpin DM,

Winter R, Hill S, Kearney M, Holton K, Moger A, Freeman D, Chisholm A, Bateman ED;

Respiratory Effectiveness Group. (2014) Opportunities to diagnose chronic obstructive

pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort.

Lancet Respir Med. 2014 Apr;2(4):267-76. doi: 10.1016/S2213-2600(14)70008-6.


Price D, Ryan D, Burden A, Von Ziegenweidt J, Gould S, Freeman D, Gruffydd-Jone K,

Copland A, Godley C, Chisholm A, Thomas M. Using fractional exhaled nitric oxide (FeNO)

to diagnose steroid-responsive disease and guide asthma management in routine care.

Clin Transl Allerggy. 2013 Nov 7;3(1):37. doi: 10.1186/2045-7022-3-37.

5 Coles Lane, Cambridge, CB24 3BA

Tel: (+44) (0) 1223 967855 Fax: (+44) (0) 808 280 0792


Price D, Small I, Haughney J, Ryan D, Gruffydd-Jones K, Lavorini F, Harris T, Burden A,

Brockman J, King C, Papi A. (2013) Clinical and cost effectiveness of switching asthma

patients from fluticasone-salmeterol to extra-fine particle beclometasone-formoterol: a

retrospective matched observational study of real-world patients. Prim Care Respir J. 2013

Dec;22(4):439-48. doi: 10.4104/pcrj.2013.00088.


Price D, Thomas M, Haughney J, Lewis RA, Burden A, von Ziegenweidt J, Chisholm A, Hillyer

EV, Corrigan CJ. (2013) Real-life comparison of beclometasone dipropionate as an

extrafine- or larger-particle formulation for asthma. Respir Med. 2013 Jul;107(7):987-1000.

doi: 10.1016/j.rmed.2013.03.009.


Price D, Lee AJ, Sims EJ, Kemp L, Hillyer EV, Chisholm A, von Ziegenweidt J, Williams A.

Characteristics of patients preferring once-daily controller therapy for asthma and chronic

obstructive pulmonary disease: retrospective observational study. Prim Care Respir J. 2013

Jun;22(2):161-8. doi: 10.4104/pcrj.2013.00017


Price D, Chisholm A, Hillyer EV, Burden A, von Ziegenweidt J, et al. (2013) Effect of Inhaled

Corticosteroid Therapy Step-Down and Dosing Regimen on Measures of Asthma Control. J

Aller Ther 4: 126. doi: 10.4172/2155-6121.1000126